Sarfez Pharmaceuticals announced approval by the U.S. Food and Drug Administration of the Virginia-based company’s New Drug Application for Soaanz, a once-a-day improved formulation of the loop diuretic torsemide.

Proposed dosing for a drug being developed by Allergan to treat frequent urination at night has been inadequately studied in trials, per an FDA preliminary review.